Related Experiment Video
Updated: Jun 12, 2026
13:34
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Simultaneously optimized support vector regression combined with genetic algorithm for QSAR analysis of KDR/VEGFR-2
Min Sun1, Junqing Chen, Jin Cai
1Southeast University, Nanjing, China.
Chemical Biology & Drug Design
|May 22, 2010
Summary
This study introduces simultaneous optimization for support vector regression (SVR) models in quantitative structure-activity relationship (QSAR) studies. The optimized SVR model significantly improves predictions for vascular endothelial growth factor receptor-2 inhibitors compared to linear models.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Drug Discovery
Background:
- Support Vector Regression (SVR) models often lack full optimization in Quantitative Structure-Activity Relationship (QSAR) studies.
- Developing accurate predictive models for kinase inhibitors is crucial for drug discovery.
- Novel naphthalene and indazole-based compounds targeting kinase insert domain receptor/vascular endothelial growth factor receptor-2 (KDR/VEGFR-2) require robust activity prediction.
Purpose of the Study:
- To propose and evaluate a simultaneous optimization strategy for SVR models in QSAR.
- To develop a highly predictive model for KDR/VEGFR-2 inhibitory activity.
- To identify key structural features influencing the biological activity of naphthalene and indazole-based inhibitors.
Main Methods:
- Feature selection using a genetic algorithm (GA) identified six optimal descriptors.
- Simultaneous optimization of SVR parameters (cost C, gamma, epsilon) was performed via grid search.
- Genetic Algorithm-Support Vector Regression (GA-SVR) model performance was validated using leave-one-out cross-validation and external validation, and compared against GA-Multiple Linear Regression (GA-MLR).
Main Results:
- The optimized GA-SVR model achieved high predictive accuracy with R(2) values of 0.908 (training) and 0.837 (test), and low RMSE of 0.237 (training) and 0.311 (test).
- GA-SVR significantly outperformed GA-MLR, which yielded R(2) of 0.764 (training) and 0.700 (test), and RMSE of 0.402 (training) and 0.421 (test).
- The study identified optimal parameters for SVR as C=1.2, gamma=0.15, and epsilon=0.065.
Conclusions:
- Simultaneous optimization enhances SVR model performance for QSAR applications.
- The developed GA-SVR model provides an efficient strategy for predicting KDR/VEGFR-2 inhibitory activity.
- The findings offer valuable insights for designing novel KDR/VEGFR-2 inhibitors.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...